Post Type Archives: News

Informa Markets will once again bring together the pharmaceutical industry at CPHI Americas 2026 (June 2-4), uniting senior leaders from across the pharmaceutical supply chain for a revamped conference focused event on contract manufacturing, regulatory change, artificial intelligence, and innovation in biologics and advanced therapies. Part of the global CPHI portfolio, the annual event serves […]

Informa Markets will once again bring together the pharmaceutical industry at CPHI Americas 2026 (June 2-4), uniting senior leaders from across the pharmaceutical supply chain for a revamped conference focused event on contract manufacturing, regulatory change, artificial intelligence, and innovation in biologics and advanced therapies. Part of the global CPHI portfolio, the annual event serves […]

Indena is proud to announce its participation in the Health Food Expo, Ingredients and Contract Manufacture 2026 in Tokyo. Leveraging the proven success and strong local presence of its Japanese branch, Indena’s participation in this event underscores its sustained and profound commitment to the thriving Japanese nutraceutical market. At this year’s expo, Indena will put […]

Ofichem has brought its brands – Ofichem BV, Ofipharma, Ofimedicine, Labatorium Ofichem, Ofichem Uppsala, and Avivia – together as one family-owned CDMO and pharmaceutical supplier, marking a strategic step in its evolution. From April 1, all business units will operate under the Ofichem trading name. The move brings together Ofichem’s capabilities across drug substance, drug […]

Neurocrine Biosciences, Inc. and Soleno Therapeutics, Inc. announced that Neurocrine has entered into a definitive agreement to acquire Soleno for $53.00 per share in cash, representing a total transaction equity value of $2.9 billion. The acquisition of Soleno and the addition of VYKAT™ XR (diazoxide choline), a first-in-class therapy to treat hyperphagia, the defining feature of […]

Resyca®, a leader in soft mist-based drug delivery with its next-generation Soft Mist Inhalers and Soft Nasal Sprays, announced the appointment of Deborah Jones, Ph.D., as Chief Executive Officer, effective immediately. She succeeds Remko Beimers, who is stepping down. The shareholders thank Mr Beimers for his leadership and significant contributions to the company’s growth and […]

Neuland Laboratories, a global contract development and manufacturing organization (CDMO) specialising in complex APIs, has today announced a leadership change. Saharsh Davuluri will assume the role of Chief Executive Officer and Managing Director, effective immediately, as the company moves into its next stage of CDMO growth. Saharsh has been with the company for more than 18 […]

Adragos Pharma, a global contract development and manufacturing organization (CDMO), today announced that it completed the acquisition of a commercial-scale sterile fill-finish facility in Maisons-Alfort, France, from Sanofi The Maisons-Alfort site is one of Europe’s largest manufacturing facilities for sterile injectables, with industrial-scale capacity for pre-filled syringes (PFS), as well as liquids and lyophilized vials. […]

Lonza announced the publication of its 2025 Annual and Sustainability Reports, as well as its invitation to the 2026 Annual General Meeting (AGM). The event will take place on Friday, 8 May 2026, at 10:00 a.m. CEST, at the Congress Center Messe Basel, Messeplatz 21, 4058 Basel, Switzerland. 2026 Annual General Meeting (AGM) The Board […]

Eli Lilly and Company and Centessa Pharmaceuticals plc, a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other neurological conditions, today announced a definitive agreement for Lilly to acquire Centessa. Centessa is advancing a pipeline of orexin receptor 2 (OX2R) agonists designed to address the neurobiological system […]